Search

"It still doesn't happen overnight — the paperwork itself, I aged like 20 years." Dr. Marisa Azad shares the real timeline and logistics behind Canada's first bone infection phage therapy case, plus why her N-of-1 approach creates a platfor

This month, Jess went viral with a post about How to Read Papers, we picked some great bread and butter papers, and Jess got to chat with Cytophage about navigating the Canadian regulatory phage maze. Welcome to summer, everyone! This mont

"There's 145 components of the regulatory requirements that I don't fit in. So how do I get past that? And governments right now say, I don't know." "Phages are not drugs. Every time they say, 'Did you go through regulatory?' I say, 'I can

"Phages? We don't use those here." This week, learn how these words propelled Sandro Sulakvelidze, fresh from phage-friendly Tbilisi, into a 25+ year journey to build a phage company with FDA-approved products. From a chance conversation ab

This week we're featuring Michael Shamash's reflections on a couple of noteworthy topics covered at this year's Hanson Wade phage summit. Michael is a McGill University PhD student by day / awesome Phage Directory volunteer by night — thank

This month, we talked about analyzing qPCR results, Phage Australia's official response to the Phage UK inquiry, and got hands on with building a project with ChatGPT! We put out some good work in April! This month we’ve been neck deep in d

This week, we look at some highlights from a white paper that Phage Australia published as a response to the UK Parliament Inquiry on phage therapy. ## Summary of The antimicrobial potential of bacteriophages – UK Parliament Inquiry 2023 R

This week, we're republishing an article Dr. Jon Iredell and Jessica Sacher wrote for GARDP Revive, the Global Antibiotic Research & Development Partnership. This Viewpoint was originally published on the REVIVE website revive.gardp.org, an

This week, Ruby CY Lin of Phage Australia dives deep into commercialization pathways and opportunities for Phage Australia, and the phage industry as a whole. In Part One of this three-part series, she explains the importance of phage manu

Patients need safe phages, but most regulators don't yet have official positions on what makes a phage batch safe. This week, Jessica Sacher (Iredell lab, Phage Australia) shares her recent foray into learning about phage quality control an

Phage Futures Europe was recently held in Amsterdam, where the phage biotech field came together to discuss recent progress in clinical phage therapy and commercialization. Jessica Neubauer and Madhav Madurantakam Royam are back this week w

Last month Madhav Madurantakam Royam and Jessica Neubauer attended Phage Futures Europe in Amsterdam, and they've brought us a sneak-peek into what they learned! The 6th annual Phage Futures conference was held on the 6th and 7th July 2022

This week, Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Jean-Paul Pirnay about how the Queen Astrid Military Hospital in Belgium is advancing phage therapy. This piece is sponsored by Kisaco Research f

From Feb 14th-16th, the who's who of the phage world is getting together to discuss everything from isolating phages from hospital wastewater to the role of the immune system in phage therapy! This week, University of Vienna MSc student Je

What brought phage therapy to where it is today? This week, we're featuring an interview with Dr. David Harper, CEO of Evolution Biotechnologies, by Curtis Hoffmann, a longtime Phage Directory volunteer. They discuss David's thoughts on his

Pranav and Apurva Johri, founders of Vitalis Phage Therapy, recently set up a new framework that allows patients in India to get phage susceptibility testing done locally. We sat down with Pranav and Apurva to learn more about what this mil

For this week's feature article, Rodrigo Monteiro and Graça Pinto interviewed University of Wroclaw Professor Zuzanna Drulis-Kawa about her phage therapy and phage depolymerase enzyme research. She shares how she navigates complex grant pro

This week, Donna May Papa, Assistant Professor at the University of Santo Tomas in Manila, Philippines, tells us about her lab's journey into phage research, and their plans for the future. Since the global antimicrobial resistance crisis h

This week, Dr. Ramesh Nachimuthu reflects on the ICBRAMR conference, which took place in Vellore, India in December 2019 and focused on the promise of phages in the fight against antimicrobial resistance. Conference theme: Paradigm shift in

This week, Dr. Urmi Bajpai, a phage researcher in New Delhi, India and co-creator of the International Bacteriophage Research Consortium, tells us about a public phage therapy lecture her Consortium held last month to raise awareness of pha